Literature DB >> 33340578

Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR-based lipoprotein profiling.

Mingfeng Xia1, Hailuan Zeng1, Sijia Wang2, Huiru Tang3, Xin Gao4.   

Abstract

Keywords:  Lipoprotein profile; MAFLD; NAFLD; PNPLA3; TM6SF2

Year:  2020        PMID： 33340578     DOI： 10.1016/j.jhep.2020.10.019

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  7 in total

Review 1.  Association of metabolic dysfunction-associated fatty liver disease with kidney disease.

Authors:  Ting-Yao Wang; Rui-Fang Wang; Zhi-Ying Bu; Giovanni Targher; Christopher D Byrne; Dan-Qin Sun; Ming-Hua Zheng
Journal:  Nat Rev Nephrol       Date:  2022-01-10       Impact factor: 28.314

Review 2.  MAFLD and CKD: An Updated Narrative Review.

Authors:  Alessandro Mantovani; Rosa Lombardi; Filippo Cattazzo; Chiara Zusi; Davide Cappelli; Andrea Dalbeni
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

Review 3.  Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science.

Authors:  Yasser Fouad; Melissa Palmer; Minjun Chen; Arie Regev; Rajarshi Banerjee; Rob Myers; Robert Riccio; Richard Torstenson; Ramy Younes; Puneet S Arora; Henrik Landgren; Morten A Karsdal; Martin Blake; David A Shapiro; Hans-Juergen Gruss; Muhammad Y Sheikh; Dina Attia; Steven Bollipo; Alastair D Smith; Bradley Freilich; Robert G Gish; Detlef Schuppan
Journal:  J Clin Transl Hepatol       Date:  2021-10-22

Review 4.  Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?

Authors:  Jalpa Devi; Aimun Raees; Amna Subhan Butt
Journal:  World J Hepatol       Date:  2022-01-27

5.  Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China.

Authors:  Shenling Liao; Kang An; Zhi Liu; He He; Zhenmei An; Qiaoli Su; Shuangqing Li
Journal:  J Clin Lab Anal       Date:  2022-07-26       Impact factor: 3.124

6.  Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease.

Authors:  Zong Miao; Kristina M Garske; David Z Pan; Amogha Koka; Dorota Kaminska; Ville Männistö; Janet S Sinsheimer; Jussi Pihlajamäki; Päivi Pajukanta
Journal:  HGG Adv       Date:  2021-08-24

Review 7.  Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities.

Authors:  Xiaomi Du; Natalie DeForest; Amit R Majithia
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-07       Impact factor: 5.555
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.